{
    "nct_id": "NCT05826275",
    "official_title": "A Phase 1 Trial of TGN-S11 in Patients With Human Papillomavirus (HPV)-Associated Relapsed, Resistant or Metastatic Cancer",
    "inclusion_criteria": "* Prior histologically confirmed HPV-associated squamous cell carcinoma, which is relapsed, resistant, or metastatic\n* Life expectancy of at least 3 months\n* Dose Escalation Phase: patients who have experienced disease progression on Standard of Care Therapies\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Active CNS metastases\n* Have any history of seizure disorder or are taking prophylactic seizure medication\n* Have an active viral, bacterial, or fungal infection",
    "miscellaneous_criteria": ""
}